SurgLine International SGLN · USD

Its shares trade under the ticker SGLN. It has been listed since 27 September 2001. In the fiscal year to 31 July 2012, it reported revenue of $113,620 and a net loss of $2.7m. At that date it held total assets of $105,681 and shareholders' equity of −$1.6m.

SurgLine International, Inc. operates as a development stage holding company, which engages in surgical and solar photovoltaic cell technology products, through its subsidiaries. The company is headquartered in West Palm Beach, Florida. The company went IPO on 2001-09-27. The Company’s core business is to source and sell surgical implants, medical, dental and surgical disposable products used by physicians and dentists. SurgLine International, Inc. and its wholly owned subsidiary SurgLine Inc is developing a physician office allergy testing program using Sublingual Immunotherapy also known as SLIT. SurgLine offers products via its website www.surglinesupplies.com. Some Its products include Spine Hardware such as Cervical PEEK Interbody Fusion Device (IBFD) , Anterior, Posterior and Transformal Lumbar Interbody Fusion (TLIF) System; Surgical Sets: includes tray, instruments, screws, implants; Surgical Instruments include Scissors, forceps, basket punches, saw blades, reamers, pulse lavage; Drill System and Power Tools include Cordless & pneumatic drills, chucks, sleeves, saws, hoes, charges and batteries.

Figures and description from our data supplier, not checked against the company's own report.

• Thomas TolandPresident, Chief Executive Officer, since 2011
• Richard DutchChief Operating Officer

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.